Breast Cancer Resistance Protein in Drug Resistance of Primitive CD34+38− Cells in Acute Myeloid Leukemia

Purpose: Acute myeloid leukemia (AML) is considered a stem cell disease. Incomplete chemotherapeutic eradication of leukemic CD34+38− stem cells is likely to result in disease relapse. The purpose of this study was to investigate the role of the breast cancer resistance protein (BCRP/ATP-binding cas...

Full description

Saved in:
Bibliographic Details
Published inClinical cancer research Vol. 11; no. 6; pp. 2436 - 2444
Main Authors RAAIJMAKERS, Marc H. G. P, DE GROUW, Elke P. L. M, HEUVER, Leonie H. H, VAN DER REIJDEN, Bert A, JANSEN, Joop H, SCHEPER, Rik J, SCHEFFER, George L, DE WITTE, Theo J. M, RAYMAKERS, Reinier A. P
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 15.03.2005
Subjects
Online AccessGet full text

Cover

Loading…